Cargando…

Small Cell Carcinoma of the Vagina: First Systematic Review of Case Reports and Proposal of a Management Algorithm

Small cell carcinoma of the vagina (SmCCV) is an extremely rare disease. Evidence-based data and specific guidelines are lacking. We conducted the first systematic review of case reports to provide the most overall picture of SmCCV. MATERIALS AND METHODS: Literature search in PubMed and Scopus was p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capote, Sira, Domènech, Marta, Valdivieso, Lorena, Tuset, Victoria, Sanchez, Myriam, Carballas, Elvira, Teruel, Iris, Durany, David, Moragas, Gloria, Molina, Carlos, Lleberia, Judith, Martínez-Roman, Sergio, Romeo, Margarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Non-HPV Associated Vulvovaginal Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770126/ https://www.ncbi.nlm.nih.gov/pubmed/36282979 http://dx.doi.org/10.1097/LGT.0000000000000712

Ejemplares similares

Learning on the Go: Assessing Knowledge Gained From Medical Podcasts Created for Vulvovaginal Disease Education
por: Dmytryshyn, Julia, et al.
Publicado: (2022)

The Impact of Psychosexual Counseling in Women With Lichen Sclerosus: A Randomized Controlled Trial
por: Vittrup, Gitte, et al.
Publicado: (2022)

The Clinicopathologic Challenge of Nonneoplastic Vulvar Acanthosis
por: Day, Tania, et al.
Publicado: (2022)

Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus
por: Söderlund, Jenni M., et al.
Publicado: (2023)

The Association Between Female Genital Schistosomiasis and Other Infections of the Lower Genital Tract in Adolescent Girls and Young Women: A Cross-Sectional Study in South Africa
por: Shukla, Jilna Dilip, et al.
Publicado: (2023)

Comorbidities in Male Patients With Lichen Sclerosus: A Case-Control Study
por: Hieta, Niina K., et al.
Publicado: (2023)

Nonsclerotic Lichen Sclerosus: Definition of a Concept and Pathologic Description
por: Day, Tania, et al.
Publicado: (2023)

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina
por: Wohlmuth, Christoph, et al.
Publicado: (2020)

Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)

Precise Measurement of the Thickness of Vaginal Intraepithelial Neoplasia
por: Cui, Can, et al.
Publicado: (2022)

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions
por: Preti, Mario, et al.
Publicado: (2022)

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia
por: Kesic, Vesna, et al.
Publicado: (2023)

Desquamative Inflammatory Vaginitis and Plasma Cell Vulvitis Represent a Spectrum of Hemorrhagic Vestibulovaginitis
por: Song, Myriarm, et al.
Publicado: (2021)

Erosive Lichen Sclerosus—A Clinicopathologic Subtype
por: Day, Tania, et al.
Publicado: (2021)

Clinicopathologic Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation
por: Day, Tania, et al.
Publicado: (2020)

Vestibulovaginal Sclerosis in a Transgender Man on Testosterone
por: O'Sullivan, Clare, et al.
Publicado: (2020)

Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation
por: Heller, Debra S., et al.
Publicado: (2020)

Prevalence and Characterization of Undiagnosed Youths at Risk of Chlamydia trachomatis Infection: A Cross-sectional Study
por: Reyes-Lacalle, Azahara, et al.
Publicado: (2022)

Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus–Related Cancers
por: Jodry, Dominique, et al.
Publicado: (2023)

Social and psychological impact of HPV testing in cervical screening: a qualitative study
por: McCaffery, K, et al.
Publicado: (2006)

AN UPWARD TREND IN DNA P16INK4A METHYLATION PATTERN AND HIGH RISK HPV INFECTION ACCORDING TO THE SEVERITY OF THE CERVICAL LESION
por: Carestiato, Fernanda Nahoum, et al.
Publicado: (2013)

Engaging health plans to prioritize HPV vaccination and initiate at age 9
por: Foley, Shaylen, et al.
Publicado: (2023)

Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023)

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
por: Saxena, Kunal, et al.
Publicado: (2023)

Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review
por: Khan, Amal, et al.
Publicado: (2023)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series
por: Kajtezovic, Sidika, et al.
Publicado: (2023)

Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study
por: Aragaw, Getie Mihret, et al.
Publicado: (2023)

The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020
por: Minihan, Adair K., et al.
Publicado: (2023)

Implementing interventions to start HPV vaccination at age 9: Using the evidence we have
por: Brandt, Heather M., et al.
Publicado: (2023)

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)

HPV vaccine recommendations by age: A survey of providers in federally qualified health centers
por: Lake, Paige, et al.
Publicado: (2023)

Epidemiology of human papillomavirus on condyloma acuminatum in Shandong Province，China
por: Yuan, Haowen, et al.
Publicado: (2023)

Feminized vaccine? Parents’ attitudes toward HPV vaccination of adolescents in Poland: A representative study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
por: Achdiat, Pati Aji, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs
por: Alsanafi, Mariam, et al.
Publicado: (2023)

Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics
por: Zorn, Sherri, et al.
Publicado: (2023)

Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
por: Miller, Meagan E., et al.
Publicado: (2023)

HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists
por: Fernandes, Annlynn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0esrcm8sq09jv7hps0gqcnedg